Antiphospholipid Syndrome and Perioperative Hemostatic Management of Cardiac Valvular Surgery
- 30 September 2000
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 75 (9) , 971-976
- https://doi.org/10.4065/75.9.971
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulantJournal of Cardiothoracic and Vascular Anesthesia, 1997
- Thrombocytopenia in the antiphospholipid syndromeBritish Journal of Haematology, 1996
- Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findingsLupus, 1996
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1995
- Criteria for the Diagnosis of Lupus Anticoagulants: An UpdateThrombosis and Haemostasis, 1995
- Primary antiphospholipid syndrome and mitral valve thrombosisAmerican Heart Journal, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- Valvular Heart Disease in the Primary Antiphospholipid SyndromeAnnals of Internal Medicine, 1992
- Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human ProthrombinThrombosis and Haemostasis, 1991
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990